ArticleExperimental hematology2022

Toll-like receptor and cytokine expression throughout the bone marrow differs between patients with low- and high-risk myelodysplastic syndromes.

Luana Chiquetto Paracatu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.